Pellegrino Antonio, Fabig Sophie-Charlotte, Kersebaum Dilara, Hüllemann Philipp, Baron Ralf, Roch Toralf, Babel Nina, Seitz Harald
Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), 14476 Potsdam, Germany.
Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
Biomedicines. 2023 Mar 2;11(3):764. doi: 10.3390/biomedicines11030764.
Polyneuropathies (PNP) are the most common type of disorder of the peripheral nervous system in adults. However, information on microRNA expression in PNP is lacking. Following microRNA sequencing, we compared the expression of microRNAs in the serum of patients experiencing chronic painful PNP with healthy age-matched controls. We have been able to identify four microRNAs (-miR-3135b, -miR-584-5p, -miR-12136, and -miR-550a-3p) that provide possible molecular links between degenerative processes, blood flow regulation, and signal transduction, that eventually lead to PNP. In addition, these microRNAs are discussed regarding the targeting of proteins that are involved in high blood flow/pressure and neural activity dysregulations/disbalances, presumably resulting in PNP-typical symptoms such as chronical numbness/pain. Within our study, we have identified four microRNAs that may serve as potential novel biomarkers of chronic painful PNP, and that may potentially bear therapeutic implications.
多发性神经病(PNP)是成人最常见的周围神经系统疾病类型。然而,关于PNP中微小RNA表达的信息尚缺。在进行微小RNA测序后,我们比较了患有慢性疼痛性PNP患者血清与年龄匹配的健康对照者血清中微小RNA的表达情况。我们已能够鉴定出四种微小RNA(-miR-3135b、-miR-584-5p、-miR-12136和-miR-550a-3p),它们在退行性过程、血流调节和信号转导之间提供了可能的分子联系,最终导致PNP。此外,还讨论了这些微小RNA对涉及高血流/血压和神经活动失调/失衡的蛋白质的靶向作用,推测这会导致PNP典型症状,如慢性麻木/疼痛。在我们的研究中,我们鉴定出四种微小RNA,它们可能作为慢性疼痛性PNP潜在的新型生物标志物,并且可能具有潜在的治疗意义。